Á lódáil...

Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical study

Ruxolitinib is the only approved therapy for myelofibrosis (MF). However, its use in patients with myeloproliferative neoplasms (MPN) not participating in clinical studies has been poorly described. We reviewed the medical records of 45 patients (35 MF, 10 others) treated with ruxolitinib at our cen...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Leuk Lymphoma
Main Authors: Naqvi, Kiran, Daver, Naval, Pemmaraju, Naveen, Bose, Prithviraj, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2016
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5521009/
https://ncbi.nlm.nih.gov/pubmed/27494751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2016.1217528
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!